ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.
Also called NCT05686317
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT05686317
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Brazil, Canada, Germany, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05686317. Randomized; double masking; primary purpose treatment. Start 2023-04-01 (actual); primary completion 2026-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System
- Acronym
- ALT-FLOW II
- Condition
- Heart Failure
- Intervention (Device)
- Edwards APTURE transcatheter shunt system
- Intervention (Diagnostic test)
- Sham procedure
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct05686317- Content hash
f4717d11ed9d8b0f2257be4de100e9a199a9c49e01288063d6bd1f9905c2d63b